AAAAAA
Results:
1-14
|
Results: 14
Authors:
GORSKI JC
JONES DR
HAEHNERDANIELS BD
HAMMAN MA
OMARA EM
HALL SD
Citation: Jc. Gorski et al., THE CONTRIBUTION OF INTESTINAL AND HEPATIC CYP3A TO THE INTERACTION BETWEEN MIDAZOLAM AND CLARITHROMYCIN, Clinical pharmacology and therapeutics, 64(2), 1998, pp. 133-143
Authors:
GORSKI JC
HAEHNER BD
CUTLER D
AFFRIME MB
HALL SD
Citation: Jc. Gorski et al., LACK OF CORRELATION BETWEEN INTRAVENOUS MIDAZOLAM AND ORAL DEXTROMETHORPHAN CYP3A PHENOTYPES, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 54-54
Authors:
STRONG ML
GORSKI JC
RUDY AC
BRATER DC
HALL SD
Citation: Ml. Strong et al., EFFECT OF KETOPROFEN ON THE RENAL EXCRETION OF SODIUM, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 100-100
Authors:
HAEHNERDANIELS BD
CUTLER DL
AFFRIME MB
GORSKI JC
HALL SD
Citation: Bd. Haehnerdaniels et al., THE SELECTIVE IN-VIVO INCREASE OF CYTOCHROME-P450 2C8 9 ACTIVITY BY INTERLEUKIN-10 (IL-10)/, Clinical pharmacology and therapeutics, 63(2), 1998, p.
Authors:
BRATER DG
SKETTINO SL
WOLFF AA
ALTO P
BECKMAN E
GORSKI JC
GOTTLIEB S
LIITTSCHWAGER EB
MOZILL D
GARZONE P
BENNETT D
REFIOR W
BELARDINELLI L
Citation: Dg. Brater et al., EFFECTS OF BG9719 (CVT-124), A NOVEL SELECTIVE A(1)-ADENOSINE RECEPTOR ANTAGONIST, ON ELECTROLYTE EXCRETION IN PATIENTS WITH CONGESTIVE-HEART-FAILURE, Circulation, 98(17), 1998, pp. 411-411
Authors:
GORSKI JC
JONES DR
WRIGHTON SA
HALL SD
Citation: Jc. Gorski et al., CONTRIBUTION OF HUMAN CYP3A SUBFAMILY MEMBERS TO THE 6-HYDROXYLATION OF CHLORZOXAZONE, Xenobiotica, 27(3), 1997, pp. 243-256
Authors:
FERGUSON JA
SUNDBLAD KJ
BECKER PK
GORSKI JC
RUDY DW
BRATER DC
Citation: Ja. Ferguson et al., ROLE OF DURATION OF DIURETIC EFFECT IN PREVENTING SODIUM RETENTION, Clinical pharmacology and therapeutics, 62(2), 1997, pp. 203-208
Authors:
LI AP
REITH MK
RASMUSSEN A
GORSKI JC
HALL SD
XU L
KAMINSKI DL
CHENG LK
Citation: Ap. Li et al., PRIMARY HUMAN HEPATOCYTES AS A TOOL FOR THE EVALUATION OF STRUCTURE-ACTIVITY RELATIONSHIP IN CYTOCHROME-P450 INDUCTION POTENTIAL OF XENOBIOTICS - EVALUATION OF RIFAMPIN, RIFAPENTINE AND RIFABUTIN, Chemico-biological interactions, 107(1-2), 1997, pp. 17-30
Authors:
JONES DR
GORSKI JC
HAMMAN MA
HALL SD
Citation: Dr. Jones et al., QUANTIFICATION OF DEXTROMETHORPHAN AND METABOLITES - A DUAL PHENOTYPIC MARKER FOR CYTOCHROME-P450 3A4 5 AND 2D6 ACTIVITY/, Journal of chromatography B. Biomedical applications, 678(1), 1996, pp. 105-111
Authors:
HAEHNER BD
GORSKI JC
VANDENBRANDEN M
WRIGHTON SA
JANARDAN SK
WATKINS PB
HALL SD
Citation: Bd. Haehner et al., BIMODAL DISTRIBUTION OF RENAL CYTOCHROME-P450 3A ACTIVITY IN HUMANS, Molecular pharmacology, 50(1), 1996, pp. 52-59
Authors:
JONES DR
GORSKI JC
HAEHNER BD
OMARA EM
HALL SD
Citation: Dr. Jones et al., DETERMINATION OF CYTOCHROME-P450 3A4 5 ACTIVITY IN-VIVO WITH DEXTROMETHORPHAN N-DEMETHYLATION/, Clinical pharmacology and therapeutics, 60(4), 1996, pp. 374-384
Authors:
GORSKI JC
JONES DR
WRIGHTON SA
HALL SD
Citation: Jc. Gorski et al., DEXTROMETHORPHAN (D) N-DEMETHYLATION (N-DME) AS AN INDEX OF CYP3A ACTIVITY, Clinical pharmacology and therapeutics, 55(2), 1994, pp. 137-137
Authors:
GORSKI JC
JONES DR
WRIGHTON SA
HALL SD
Citation: Jc. Gorski et al., CHARACTERIZATION OF DEXTROMETHORPHAN N-DEMETHYLATION BY HUMAN LIVER-MICROSOMES - CONTRIBUTION OF THE CYTOCHROME-P450 3A (CYP3A) SUBFAMILY, Biochemical pharmacology, 48(1), 1994, pp. 173-182
Authors:
GORSKI JC
HALL SD
VANDENBRANDEN M
WRIGHTON SA
JONES DR
Citation: Jc. Gorski et al., REGIOSELECTIVE BIOTRANSFORMATION OF MIDAZOLAM BY MEMBERS OF THE HUMANCYTOCHROME-P450-3A (CYP3A) SUBFAMILY, Biochemical pharmacology, 47(9), 1994, pp. 1643-1653
Risultati:
1-14
|